AGILENT TECHNOLOGIES, INC.

Agilent Technologies, Inc. (NYSE: A) operates as a global leader in life sciences, diagnostics, and applied markets, providing comprehensive laboratory solutions that span the entire analytical workflow. The company's website is www.agilent.com.

The company serves customers through three primary reportable segments established following a November 2024 organizational restructuring. The Life Sciences and Diagnostics Markets segment comprises seven business areas including liquid chromatography and mass spectrometry platforms, cell analysis instruments, specialty contract development and manufacturing services for pharmaceutical customers, pathology solutions for cancer diagnostics, companion diagnostics development, genomics reagents and arrays, and biomolecular analysis tools. The Agilent CrossLab segment provides extensive services and consumables spanning the entire laboratory, including maintenance, repairs, training, software solutions through the OpenLab platform, laboratory automation, and chemistries and supplies. The Applied Markets segment delivers instruments and software for identifying and analyzing physical and biological properties of substances, including gas chromatography, mass spectrometry, spectroscopy, vacuum technology, and remarketed instruments.

Agilent employs approximately 18,100 people worldwide as of October 31, 2025, distributed across its three segments with 6,300 in Life Sciences and Diagnostics Markets, 7,400 in Agilent CrossLab, and 2,500 in Applied Markets. The company maintains primary research, development, and manufacturing sites across multiple U.S. states including California, Colorado, Delaware, Massachusetts, Texas, and Vermont, with additional facilities in Australia, Canada, China, Denmark, Germany, Italy, Japan, Malaysia, Singapore, and the United Kingdom.

The company serves approximately 99,100 total customers across its segments, including pharmaceutical and biopharmaceutical companies, clinical and academic institutions, government agencies, and industrial customers in chemicals, food, environmental, and forensics markets. Agilent's business model emphasizes direct sales supplemented by distributors, resellers, and electronic commerce channels. The company supports its diverse product portfolio through advanced manufacturing techniques, supply chain management systems, and a global infrastructure organization providing shared services in finance, information technology, legal, procurement, and human resources.